Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
SBBP similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-215532 and Form F-3 No. 333-215531) of our report dated April 4, 2017, with respect to the consolidated financial statements of Strongbridge Biopharma plc included in this Annual Report (Form 20-F) for the year ended December 31, 2016.
|
|
|
|
| /s/ Ernst & Young LLP |
Philadelphia, Pennsylvania
April 4, 2017